The CIDI-SAM is a fully-structured interview that ascertains DSM-III, DSM-III-R, Feighner, RDC and ICD-10 diagnoses for alcohol, tobacco and nine classes of psychoactive drugs, h was designed at the request of the WHO/ADAMHA Task Force on Psychiatric Assessment instruments to expand the substance abuse sections of the CIDI.
There are newer structured interviews that are more compatible with current diagnostic criteria. This includes the SCID for research purposes.
For clinical utility and well as research capabilities the CAAPE-5 may be a more feasible DSM-5 compatible tool. It is available in both paper (The Change Companies) and online versions and covers substance use disorders and the more commonly co-occurring mental health conditions. The advantage of the online version on a HIPAA compliant website (evincediagnostics.com) is that that system saves the item responses on a de-identified file for research applications.